GR910100087A - Πολυπεπτιδικα αναλογα της απολιποπρωτεινης ε. - Google Patents

Πολυπεπτιδικα αναλογα της απολιποπρωτεινης ε.

Info

Publication number
GR910100087A
GR910100087A GR910100087A GR910100087A GR910100087A GR 910100087 A GR910100087 A GR 910100087A GR 910100087 A GR910100087 A GR 910100087A GR 910100087 A GR910100087 A GR 910100087A GR 910100087 A GR910100087 A GR 910100087A
Authority
GR
Greece
Prior art keywords
apolipoprotein
polypeptide
person
polypeptide analogs
lrklrkrllrdaddl
Prior art date
Application number
GR910100087A
Other languages
English (en)
Inventor
K Linda Curtiss
A Cheryl Dyer
Richard Smith
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of GR910100087A publication Critical patent/GR910100087A/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Η παρούσα εφεύρεσις αφορά εις μέ?οδον ?εραπείας της υπερ- χοληστεριναιμίας εις ασ?ενή, ήτις μέ?οδος περιλαμβάνει την χορήγησιν εις τον ασ?ενή μιας μειούσης την εις το πλάσμα συγκέντρωσιν της LDL ποσότητας πολυμερούς πολυπεπτιδίου δυναμένου να δεσμεύσει τον υποδοχέα της LDL. Η επαναλαμβανομένη μονάς του πολυπεπτιδίου έχει αλληλουχίαν ριζών αμινοξέων αντιστοιχούσαν εις την αντιπροσωπευομένην υπό του τύπου: LRKLRKRLLRDADDL ω
GR910100087A 1990-02-26 1991-02-21 Πολυπεπτιδικα αναλογα της απολιποπρωτεινης ε. GR910100087A (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/485,158 US5182364A (en) 1990-02-26 1990-02-26 Polypeptide analogs of apolipoprotein E

Publications (1)

Publication Number Publication Date
GR910100087A true GR910100087A (el) 1992-06-30

Family

ID=23927117

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910100087A GR910100087A (el) 1990-02-26 1991-02-21 Πολυπεπτιδικα αναλογα της απολιποπρωτεινης ε.

Country Status (2)

Country Link
US (1) US5182364A (el)
GR (1) GR910100087A (el)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2137814A1 (en) * 1992-06-12 1993-12-23 Maryvonne Rosseneu New peptides and proteins, process for their preparation and their use as cholesterol acceptors
DE69333461T2 (de) * 1992-10-13 2005-03-24 Duke University VERFAHREN ZUM nachweis der Alzheimer Krankheit
US6277874B1 (en) * 1996-07-09 2001-08-21 University Of Cincinnati And Apologic, Incorporated Methods for the treatment of apolipoprotein E related diseases
US7205280B2 (en) 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
US20030077641A1 (en) * 1998-03-11 2003-04-24 Laskowitz Daniel T. Methods of suppressing microglial activation and systemic inflammatory responses
IL139217A0 (en) * 2000-03-13 2001-11-25 Applied Research Systems Monoclonal antibodies to the human ldl receptor, their production and use
CA2428114C (en) * 2000-11-10 2013-07-23 Proteopharma Aps Apolipoprotein analogues
WO2004004774A2 (en) * 2002-07-03 2004-01-15 Esperion Therapeutics, Inc. Compositions comprising panthetine for the treatment of dyslipidemia
CN101084002B (zh) 2004-09-02 2015-01-21 克格诺西有限公司 改进的apo e类似物及其使用方法
US8034762B2 (en) 2004-09-02 2011-10-11 Cognosci, Inc. Treatment of subarachnoid hemorrhage with Apo E analogs
US20080206142A1 (en) * 2006-06-16 2008-08-28 Lipid Sciences, Inc. Novel Peptides That Promote Lipid Efflux
US20080227686A1 (en) * 2006-06-16 2008-09-18 Lipid Sciences, Inc. Novel Peptides that Promote Lipid Efflux
WO2007149355A2 (en) * 2006-06-16 2007-12-27 Lipid Sciences, Inc. Novel peptides that promote lipid efflux
US20080138284A1 (en) * 2006-09-26 2008-06-12 Lipid Sciences, Inc. Novel Peptides That Promote Lipid Efflux
SG10201901089TA (en) 2008-11-10 2019-03-28 Arbutus Biopharma Corp Novel lipids and compositions for the delivery of therapeutics
EP3243504A1 (en) 2009-01-29 2017-11-15 Arbutus Biopharma Corporation Improved lipid formulation
AU2010223967B2 (en) 2009-03-12 2015-07-30 Alnylam Pharmaceuticals, Inc. Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
SG10201402054UA (en) 2009-05-05 2014-09-26 Muthiah Manoharan Lipid compositions
HUE056773T2 (hu) 2009-06-10 2022-03-28 Arbutus Biopharma Corp Továbbfejlesztett lipid készítmény
AP2015008874A0 (en) 2009-08-14 2015-11-30 Alnylam Pharmaceuticals Inc Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
WO2011071860A2 (en) 2009-12-07 2011-06-16 Alnylam Pharmaceuticals, Inc. Compositions for nucleic acid delivery
AU2010330814B2 (en) 2009-12-18 2017-01-12 Acuitas Therapeutics Inc. Methods and compositions for delivery of nucleic acids
US20130156845A1 (en) 2010-04-29 2013-06-20 Alnylam Pharmaceuticals, Inc. Lipid formulated single stranded rna
US20130123338A1 (en) 2010-05-12 2013-05-16 Protiva Biotherapeutics, Inc. Novel cationic lipids and methods of use thereof
WO2011141704A1 (en) 2010-05-12 2011-11-17 Protiva Biotherapeutics, Inc Novel cyclic cationic lipids and methods of use
IL300109A (en) 2010-06-03 2023-03-01 Alnylam Pharmaceuticals Inc Biodegradable lipids for the transfer of active substances
US20130323269A1 (en) 2010-07-30 2013-12-05 Muthiah Manoharan Methods and compositions for delivery of active agents
US20130202652A1 (en) 2010-07-30 2013-08-08 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
CN110123830A (zh) 2010-11-09 2019-08-16 阿尔尼拉姆医药品有限公司 用于抑制Eg5和VEGF基因的表达的脂质配制的组合物和方法
EP3202760B1 (en) 2011-01-11 2019-08-21 Alnylam Pharmaceuticals, Inc. Pegylated lipids and their use for drug delivery
AU2012315965A1 (en) 2011-09-27 2014-04-03 Alnylam Pharmaceuticals, Inc. Di-aliphatic substituted PEGylated lipids
US9610324B2 (en) 2012-07-11 2017-04-04 Esperion Therapeutics, Inc. Apolipoprotein mixtures

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643988A (en) * 1984-05-15 1987-02-17 Research Corporation Amphipathic peptides
ZA884504B (en) * 1987-06-29 1989-03-29 Merrell Dow Pharma Immunosuppressant peptides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CLAIMS SEARCHED: ALL *
No further relevant documents have been disclosed. *

Also Published As

Publication number Publication date
US5182364A (en) 1993-01-26

Similar Documents

Publication Publication Date Title
GR910100087A (el) Πολυπεπτιδικα αναλογα της απολιποπρωτεινης ε.
DK0503648T3 (da) CD2-bindingsdomæne af lymfocytfunktion-associeret antigen 3
DK0636173T3 (da) Behandling af HIV associeret immunthrombocytopenisk purpura
ATE121389T1 (de) Ringverknüpfte analoge von stickstoffenthaltenden nichtaromatischen heterocyclen.
DK0787141T3 (da) Fremgangsmåde til sulfonylering, sulfenylering og phosphorylering af cykliske depsipeptider
DE69212203D1 (de) Intrakorporale injizierbare Zusammensetzung zum Implantieren von hochkonzentriertem vernetzten Atelokollagen
GR1000456B (el) Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιλαμβανουν κυκλοσπορινες.
TJ392B (en) Fraction of copolymer-1 and method prodaction of it, composition for the treatment of multiple sclerosis, farmaceutical composition, method for the t reatment of multiple sclerosis.
DK0735893T3 (da) PAN DR-bindende peptider til styrkelse af immunsvaret
GR920100471A (el) Κα?αρισμένη ανοσογλοβουλίνη.
AR247590A1 (es) Una secuencia de adn que codifica derivados de factor viii humano recombinante y un procedimiento para su obtencion
NO904291D0 (no) Fremgangsmaate for fremstilling av radiomerkede antikoagulerende peptider.
ATE194168T1 (de) Varianten in den leltin domäne von selektin
NO953882L (no) Biologisk aktive polypeptidfusjonsdimerer
ES2196088T3 (es) Analogos del factor de crecimiento de los queratinocitos.
ES2046510T3 (es) Procedimiento de preparacion de polimeros yodados.
NO175313C (no) Joderte polymerer og deres anvendelse
DK0994884T3 (da) Diphosphonsyresalte til behandling af osteoporose
ATE165369T1 (de) Antikoagulierende peptide
DK258283A (da) Fremgangsmaade til fremstilling af et heparinfragment med en molekylvaegt paa 2000 til 5500 og kovalent bundet til antithrombin iii
HU9300191D0 (en) Anti-coagulant peptides
DE69334156D1 (de) Verfahren zur Reduzierung der Immunogenizität der variablen Regionen von Antikörpern
ATE174932T1 (de) Modifizierte vip-derivate und sie enthaltende pharmazeutische zusammensetzungen
ATE395361T1 (de) Das h-y antigen
DK0464488T3 (da) Optisk aktive N-alfa-fluoracryloylaminosyre-derivater, deres fremstilling, de deraf fremstillede optisk aktive polymerer og deres anvendelse til spaltning af racemater